Bod teams up with Chemist Warehouse to distribute medicinal cannabis products

Bod teams up with Chemist Warehouse to distribute medicinal cannabis products

After securing its first prescription approval for MediCabilis in October, Bod (ASX: BDA) has announced a partnership with a leading pharmacy chain to distribute its hero product.

Chemist Warehouse will manage the dispensing of Bod's medicinal cannabis products nationally, starting with its pharma grade CBD oil MediCabilis.

The Cannabis company, which Business News Australia named the 14th largest cannabis company in the country, will also initiate a training program for pharmacists at Chemist Warehouse.

The program will educate participants on all aspects of dispensing MediCabilis to eligible patients, as well as the potential benefits of medicinal cannabis and changes to the regulatory landscape.

Bod Australia CEO Jo Patterson says the deal with Chemist Warehouse is just the start of its rollout of MediCabilis nationally.

"This is an exceptional development for Bod Australia," says Patterson.

"Bod will continue to target additional pharmacy groups and potential distribution partners to drive product uptake."

Shares in Bod are up 16.07 per cent to $0.65 per share at 11.24am AEDT.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

How communications technology can raise the bar on customer service, employee experience
Partner Content
From capturing feedback early to providing messages with a higher rate of cut-through, ...
Advertisement

Related Stories

Lewis Land steps up plans for $1.5b Harbour Shores amid Gold Coast housing crunch

Lewis Land steps up plans for $1.5b Harbour Shores amid Gold Coast housing crunch

Sovereign Islands developer Lewis Land Group has stepped up the pac...

FDA clears path for Bubs baby formula expansion in the US

FDA clears path for Bubs baby formula expansion in the US

An emergency policy in the United States to allow fast-tracked impo...

Steve McCann steps down as Crown Resorts CEO, replaced by Wynn Macau executive

Steve McCann steps down as Crown Resorts CEO, replaced by Wynn Macau executive

Following the $8.9 billion takeover of Crown Resorts by US investme...

Hard seltzer start-up enters non-alcoholic market with launch of Fellr Free

Hard seltzer start-up enters non-alcoholic market with launch of Fellr Free

Alcoholic pre-mix brand Fellr is expanding its core range of produc...